Optum moves forward in $3.3B deal: What ASCs need to know 

Earlier this month, Amedisys shareholders approved a $3.3 billion acquisition by Optum. 

Advertisement

Here’s what ASCs need to know:

  1. There were more than 25 million votes in favor — 30,000 against and 67,000 abstensions. 
  2. Optum announced plans to merge with Baton Rouge, La.-based home and hospice care provider in June. 
  3. The deal is facing scrutiny from the Justice Department, which requested additional information about the proposed merger in August. Additionally, the department extended the waiting period for the deal under federal law.
  4. An Amedisys stockholder also filed a lawsuit against the company in August — seeking to stop the purchase and alleging that directors misrepresented key information in a proxy statement related to the proposed acquisition.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.